ClinicalTrials.gov record
Completed Phase 3 Interventional

Fluoxetine vs EMDR to Treat Post-Traumatic Stress Disorder (PTSD)

ClinicalTrials.gov ID: NCT00000379

Public ClinicalTrials.gov record NCT00000379. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 7, 2026, 9:03 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Treatment of Outcomes of Fluoxetine vs EMDR in PTSD

Study identification

NCT ID
NCT00000379
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Boston University
Other
Enrollment
Not listed

Conditions and interventions

Interventions

  • EMDR Behavioral
  • Fluoxetine Drug

Behavioral · Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 1998
Primary completion
Not listed
Completion
Nov 30, 2003
Last update posted
Feb 19, 2014

1999 – 2003

United States locations

U.S. sites
1
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
The Trauma Center Brookline Massachusetts 02446

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00000379, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 19, 2014 · Synced May 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00000379 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →